Epilepsy
On a bold mission to re-engineer brain parts
A European consortium is on a quest to restore typical brain activity in people with epilepsy, using a mash-up of custom organoids, microelectronics and artificial intelligence.
On a bold mission to re-engineer brain parts
Into the woods with Susan Masino
When she isn't researching the links between metabolism and brain activity, this neuroscientist logs time in forests and advocates for protecting green spaces.
Cortical interneurons derive differently in human brains
Excitatory neurons and some inhibitory neurons in the adult human cortex share parents, challenging the longstanding idea that the two cell types have different origins.
Cortical interneurons derive differently in human brains
‘Into the wild’: Moving studies of memory and learning out of the lab
People with electrodes embedded deep in their brain are collaborating with a growing posse of plucky researchers to uncover the mysteries of real-world recall.
‘Into the wild’: Moving studies of memory and learning out of the lab
New template streamlines sharing clinical trial results
This month’s Going on Trial newsletter explores a new tool for communicating with clinical trial participants and their families, among other drug development news.
New template streamlines sharing clinical trial results
Uncertainty and excitement surround one company’s cell therapy for epilepsy
After 10 years of work, Neurona may have the data to quiet its skeptics. But its ongoing clinical trial will be the ultimate test.
Uncertainty and excitement surround one company’s cell therapy for epilepsy
Mutations in multipurpose gene deal dendrites a double whammy
The mutations disrupt protein translation as well as the cell’s skeleton, according to a new study.
Mutations in multipurpose gene deal dendrites a double whammy
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Despite grave side effects, it’s vital to keep developing treatments for rare genetic forms of childhood epilepsy, says West, president of the KCNT1 Epilepsy Foundation and father of a son with the condition.
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Brain-surgery-free probes can record single-neuron activity
The new devices, which monitor neural activity from within blood vessels, show long-term stability in rats and could one day deliver electrical stimulation.
Brain-surgery-free probes can record single-neuron activity
Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data
This month’s issue of the Going on Trial newsletter explores why it’s more fun to have a beer with friends than by yourself — and how that informs an ongoing clinical trial for autism.
Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data
Explore more from The Transmitter
Robots boost data consistency in rodent studies reliant on mechanical, optogenetic stimulation
Two new devices take experimenter variation out of the equation, the lead investigators say.
Robots boost data consistency in rodent studies reliant on mechanical, optogenetic stimulation
Two new devices take experimenter variation out of the equation, the lead investigators say.
Spina bifida; MDMA effects in a mouse model of autism; maternal autoantibodies
Here is a roundup of autism-related news and research spotted around the web for the week of 13 May.
Spina bifida; MDMA effects in a mouse model of autism; maternal autoantibodies
Here is a roundup of autism-related news and research spotted around the web for the week of 13 May.
Autism research is becoming more diverse but not yet more global
Hosting the International Society for Autism Research annual meeting—which starts tomorrow—in Australia takes a step in that direction, making it easier for researchers, clinicians and advocates from the Western Pacific Region to participate.
Autism research is becoming more diverse but not yet more global
Hosting the International Society for Autism Research annual meeting—which starts tomorrow—in Australia takes a step in that direction, making it easier for researchers, clinicians and advocates from the Western Pacific Region to participate.